Tom Murphy

AP Business Writer

Industrial Media Unboxing Video

Industrial Media Unboxing Video

IEN Unboxed is a new show in which our editors unbox new tools on the market and discuss their features.

Vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company's facility in Puurs, Belgium, March 2021.

Pfizer Seeks OK for Vaccine Booster Dose

The U.S. booster plan calls for an extra dose eight months after people get their second shot.

OxyContin pills at a pharmacy in Montpelier, Vt., Feb. 19, 2013.

Senators Question FDA's Work with Opioid Maker Consultant

The agency paid McKinsey and Co. more than $140 million since 2008.

This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. The drugmaker will stop developing two potential COVID-19 vaccines after seeing poor results in early-stage studies. The company said Monday, Jan. 25, 2021, that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.

Merck Ends Development of Two Potential COVID-19 Vaccines

Early-stage studies were yielding poor results.

J&J Bolsters Outlook After Surprising Quarter

The company bumped up its 2020 forecast even after COVID-19 contributed to a 40% drop in U.S. medical device sales.